# AstraZeneca Continent B.V. > Dutch company **Wikidata**: [Q100322858](https://www.wikidata.org/wiki/Q100322858) **Source**: https://4ort.xyz/entity/astrazeneca-continent-b-v ## Summary AstraZeneca Continent B.V. is a Dutch private limited company (besloten vennootschap) headquartered in The Hague, serving as a subsidiary of AstraZeneca with operations across Europe, including Latvia. ## Key Facts - **Legal Form**: Besloten vennootschap (private limited company under Dutch law) - **Country of Operation**: Netherlands - **Headquarters**: The Hague, Netherlands - **Parent Organization**: AstraZeneca - **Official Name**: AstraZeneca Continent B.V. - **Dutch Chamber of Commerce (KVK) ID**: 27127307 - **OpenCorporates ID**: nl/27127307 - **Subsidiary Operations**: AstraZeneca Latvija, SIA (established April 26, 2019) - **Described At**: BedrijvenMonitor (Dutch business registry) - **Wikidata Classification**: Dutch company ## FAQs **What is the legal structure of AstraZeneca Continent B.V.?** It operates as a besloten vennootschap, a Dutch private limited company providing liability protection for its shareholders while restricting share transfers. **Where is AstraZeneca Continent B.V. headquartered?** Its headquarters are located in The Hague, the administrative capital of the Netherlands, which hosts numerous international organizations and government bodies. **What is the relationship between AstraZeneca Continent B.V. and its parent company?** It functions as a subsidiary of AstraZeneca, the multinational pharmaceutical corporation, with specific operations including management of AstraZeneca Latvija, SIA in Latvia. **How is the company identified in business registries?** It is registered under KVK ID 27127307 in the Netherlands and indexed as nl/27127307 on OpenCorporates, with detailed financial information available through BedrijvenMonitor. ## Why It Matters AstraZeneca Continent B.V. serves as a critical European hub for AstraZeneca's pharmaceutical operations, enabling streamlined distribution and regulatory compliance across multiple markets. Its strategic location in The Hague leverages the city's international legal infrastructure, facilitating partnerships with global health organizations and government agencies. The subsidiary model allows AstraZeneca to maintain localized operations while benefiting from the Netherlands' favorable business climate and advanced logistics networks. ## Notable For - **Strategic European Hub**: Functions as AstraZeneca's continental European subsidiary, coordinating operations across multiple countries including Latvia. - **The Hague Advantage**: Utilizes the city's status as the Netherlands' administrative capital and international justice hub for regulatory and diplomatic activities. - **Dutch Corporate Structure**: Operates under the besloten vennootschap legal framework, offering liability protection with Dutch regulatory oversight. - **Subsidiary Network**: Manages AstraZeneca Latvija, SIA since 2019, extending its operational reach into the Baltic region. ## Body ### Corporate Structure and Operations AstraZeneca Continent B.V. is a besloten vennootschap (Dutch private limited company) headquartered in The Hague, Netherlands. As a subsidiary of AstraZeneca, it oversees continental European operations, including management of AstraZeneca Latvija, SIA in Latvia since April 26, 2019. The company operates under Dutch jurisdiction with its primary business activities centered on pharmaceutical distribution, regulatory compliance, and regional market coordination. ### Legal and Administrative Framework The entity is formally registered with the Dutch Chamber of Commerce (KVK) under ID 27127307, classifying it as a private limited company. Its legal structure provides liability protection for shareholders while imposing restrictions on share transfers, aligning with Dutch corporate law. The company's official name, "AstraZeneca Continent B.V.", reflects its continental European operational scope within AstraZeneca's global network. ### Geographic and Strategic Context Headquartered in The Hague, the company benefits from the city's dual role as the Netherlands' administrative capital and a center for international law and diplomacy. This location facilitates engagement with global health organizations, government agencies, and legal institutions. The Netherlands' membership in the European Union and Schengen Area enables seamless cross-border operations, while the country's advanced infrastructure supports efficient pharmaceutical distribution networks. ### Parent Company Integration As a direct subsidiary of AstraZeneca, the entity aligns with the parent company's global pharmaceutical operations. Its responsibilities include managing regional subsidiaries like AstraZeneca Latvija, SIA, which handles market-specific regulatory and commercial activities. This subsidiary relationship allows AstraZeneca to maintain localized market presence while leveraging centralized strategic oversight from The Hague. ### Identifiers and Registry Presence The company is uniquely identified through multiple business registries: - **KVK ID**: 27127307 (Dutch Chamber of Commerce) - **OpenCorporates ID**: nl/27127307 - **BedrijvenMonitor**: Detailed financial and operational data available at https://bedrijvenmonitor.info/bedrijf/financiele-instellingen/astrazeneca-continent-b-v/kvknummer/271273070000 These identifiers facilitate transparency in corporate reporting and regulatory compliance across European markets. ### Subsidiary Management AstraZeneca Continent B.V. oversees AstraZeneca Latvija, SIA, established in Latvia on April 26, 2019. This subsidiary manages market-specific pharmaceutical operations, including regulatory submissions, distribution logistics, and commercial activities within Latvia's healthcare system. The arrangement allows AstraZeneca to maintain dedicated regional expertise while benefiting from centralized continental coordination. ## References 1. [Source](https://info.ur.gov.lv/#/legal-entity/40103252820) 2. [Source](https://www.kvk.nl/bestellen/#/27127307)